Treace Medical Concepts reported solid revenue growth and successful product expansion, with strong financial management and strategic initiatives poised for future growth. However, the company still faces challenges with a net loss and slight gross margin decline. Overall, the outlook remains positive, with expectations for a stronger second half of 2025.

Company Guidance -

Q3 2025

In the second quarter of 2025, Treace Medical Concepts reported revenue of $47.4 million, reflecting a 7% increase compared to the same period in 2024. The company's gross margin was 79.7%, slightly down from 80.2% in the previous year. Operating expenses decreased by 4% to $54.7 million, demonstrating effective expense management. The net loss improved by 18% to $17.4 million, or $0.28 per share, compared to the prior year's loss of $21.2 million, or $0.34 per share. Treace also reported a 58% improvement in adjusted EBITDA loss, bringing it to $3.6 million. The company maintained liquidity with $69.3 million in cash, cash equivalents, and marketable securities, and total liquidity, including an additional $21.4 million from an existing revolver, amounted to $90.7 million. Treace reiterated its 2025 revenue guidance between $224 million and $230 million, representing a 7% to 10% growth over 2024, and aims to achieve breakeven adjusted EBITDA for the full year.

Revenue Growth Achieved

Treace Medical Concepts reported a revenue of $47.4 million for Q2 2025, marking a 7% increase over the second quarter of 2024.

Expansion of Product Portfolio

The company expanded its product portfolio with three new bunion correction systems: Nanoplasty, Percuplasty 3D MIS osteotomy systems, and SpeedMTP Great Toe Fusion system.

Improved Financial Metrics

Treace Medical reported a net loss improvement of 18%, with adjusted EBITDA loss improving by 58% compared to Q2 2024.

Strong Cash Management

Cash usage decreased by 55% in Q2 2025 compared to the previous year, with a projected 50% reduction for the full year.

Market Expansion Strategy

The company's strategy includes increasing market penetration by engaging new surgeons and expanding their customer base.

Treace Medical Concepts (TMCI) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

TMCI Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 11, 2025	2025 (Q3)	-0.28 / -	-0.25	―	―	―
Aug 07, 2025	2025 (Q2)	-0.29 / -0.28	-0.34	17.65% (+0.06)	―
May 08, 2025	2025 (Q1)	-0.30 / -0.25	-0.3	16.67% (+0.05)	―
Feb 27, 2025	2024 (Q4)	-0.04 / -0.01	-0.1	90.00% (+0.09)	―
Nov 05, 2024	2024 (Q3)	-0.27 / -0.25	-0.28	10.71% (+0.03)	―
Aug 06, 2024	2024 (Q2)	-0.29 / -0.34	-0.2	-70.00% (-0.14)	―
May 07, 2024	2024 (Q1)	-0.30 / -0.30	-0.23	-30.43% (-0.07)	―
Feb 27, 2024	2023 (Q4)	-0.09 / -0.10	-0.08	-25.00% (-0.02)	―
Nov 09, 2023	2023 (Q3)	-0.26 / -0.28	-0.22	-27.27% (-0.06)	―
Aug 08, 2023	2023 (Q2)	-0.24 / -0.20	-0.231	13.42% (+0.03)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

TMCI Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 07, 2025	$5.68	$6.13	+7.92%
May 08, 2025	$7.54	$6.82	-9.55%
Feb 27, 2025	$9.13	$8.94	-2.08%
Nov 05, 2024	$5.76	$7.78	+35.07%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Treace Medical Concepts, Inc. (TMCI) report earnings?

Treace Medical Concepts, Inc. (TMCI) is schdueled to report earning on Nov 11, 2025, After Close (Confirmed).

What is Treace Medical Concepts, Inc. (TMCI) earnings time?

Treace Medical Concepts, Inc. (TMCI) earnings time is at Nov 11, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is TMCI EPS forecast?

TMCI EPS forecast for the fiscal quarter 2025 (Q3) is -0.28.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing